Group One Trading’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-51
Closed -$1.5K 8489
2023
Q2
$1.5K Hold
51
﹤0.01% 7170
2023
Q1
$1.19K Sell
51
-73
-59% -$1.97K ﹤0.01% 6754
2022
Q4
$1.79K Sell
124
-237
-66% -$4.57K ﹤0.01% 6692
2022
Q3
$9K Sell
361
-155
-30% -$4K ﹤0.01% 6583
2022
Q2
$10K Buy
516
+38
+8% +$843 ﹤0.01% 6783
2022
Q1
$17K Sell
478
-19
-4% -$706 ﹤0.01% 6888
2021
Q4
$22K Buy
497
+80
+19% +$4.8K ﹤0.01% 6933
2021
Q3
$30K Buy
+417
New +$47.4K ﹤0.01% 6924

Other funds holding ASLN

Group One Trading's ASLN Position: Q3 2023 in Review

Group One Trading sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2023, closing a stake of 51 shares — an estimated $1.5K sold.

Group One Trading first reported a position in ASLN in Q3 2021 and held it in 8 quarters. The position peaked at $30K in Q3 2021. 19 funds tracked by Wall St. Rank hold ASLN as of Q3 2023.

  • Group One Trading reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 51 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2023, an estimated $1.5K.
  • Group One Trading first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 8 quarters.
  • Group One Trading's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $30K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.